Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ALTISOURCE PORTFOLIO SOLUTIONS S.A. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
997
942
838
649
366
178
153
145
160
171
Cost of revenue
690
700
622
493
305
171
131
115
111
122
Gross profit
307
242
216
155
60.4
7.09
21.8
29.7
49.5
48.9
Selling, general and administrative
214
193
176
141
92.7
67
54.8
46.4
45.6
41
Operating income
65.1
49.7
42.5
18.1
-44.4
29
-33.2
-16.8
3.22
0.42
Interest expense
24.4
22.3
26.3
21.4
17.7
14.5
16.6
36.1
38.9
12.2
Interest income
0.09
0.27
0.74
0.34
0.11
0
0.67
1.31
1.03
1.4
Other non-operating income
-20.8
-14.3
-41.1
-5.61
-13.4
-13.7
-14.4
-35.6
-36.1
-14.6
Pre-tax income
44.3
35.4
1.4
12.4
-57.7
15.3
-47.6
-52.3
-32.9
-14.1
Income tax
12.9
-276
4.1
318
8.61
3.23
5.27
3.71
2.58
-16.1
Net income to minority interests
2.69
2.74
2.68
2.11
0.84
0.24
0.59
0.23
0.19
0.31
Net income
28.7
309
-5.38
-308
-67.2
11.8
-53.4
-56.3
-35.6
1.62
EBITDA
102
86.2
73.3
36.6
-29.5
33.6
-29.7
-14.4
4.22
0.93
EPS, basic
12.23
135.78
-2.56
-153.93
-34.45
5.99
-26.53
-20.06
-9.99
0.16
EPS, diluted
11.67
132.11
-2.56
-153.93
-34.45
5.91
-26.53
-20.06
-9.99
0.15
Shares, basic (weighted)
2.34
2.28
2.14
2
1.95
1.98
2.01
2.81
3.57
10.1
Shares, diluted (weighted)
2.45
2.34
2.14
2
1.95
2.01
2.01
2.81
3.57
11.1
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
149
105
58.3
82.7
58.3
98.1
51
32.5
29.8
26.6
Receivables
87.8
52.7
36.5
43.6
22.4
18
13
11.7
15.1
18
Other current assets
6.89
10.2
9.7
4.27
5.1
6.88
2.63
2.74
0.59
0.92
Total current assets
325
272
202
184
100
138
87.6
55.5
51.1
54.3
Property, plant and equipment
103
73.3
45.6
24.5
11.9
6.87
4.22
1.71
0.7
0.25
Lease right-of-use assets
0
29.1
18.2
7.59
5.32
3.38
2.24
1.12
Goodwill
86.3
86.3
81.4
73.8
73.8
56
56
56
56
56
Intangible assets
155
120
91.7
61
46.3
36.9
31.7
26.5
21.5
17.1
Other non-current assets
11.3
10.2
12.4
10.8
9.85
6.13
5.43
6.73
6.5
4.77
Total assets
689
865
742
394
266
258
195
155
144
140
Accounts payable
8.79
15.7
27.9
22.4
16.8
16
15
15.3
17.9
13.5
Accrued liabilities
26.4
27.3
27.9
24.6
24.4
13.7
11.9
8.64
9.59
17.3
Deferred revenue
8.8
9.8
10.1
5.18
5.46
4.34
3.71
3.2
3.98
3.44
Short-term debt
5.95
5.95
0
0
0
231
1.23
Total current liabilities
149
110
104
87.6
71.5
54.7
40.1
35.8
271
47.1
Long-term debt
468
403
331
288
243
244
245
216
0
190
Lease liabilities
0
19.7
12.3
5.03
3.37
1.95
0.83
0.25
Other non-current liabilities
10.5
12.3
9.18
31
25.2
19.3
19.5
19.5
20
3.7
Total liabilities
627
525
445
416
348
327
314
280
300
249
Total debt
474
409
331
288
243
244
245
216
231
191
Paid-in capital
107
112
123
134
141
144
149
177
212
257
Retained earnings
334
627
591
272
190
187
119
-180
-260
-364
Treasury stock
-404
-427
-443
-454
-441
-426
-413
-153
-109
-3.95
Other comprehensive income
-1.75
0.73
0
Shareholders' equity
60.8
339
295
-22.8
-83.8
-70.1
-120
-126
-157
-110
Minority interests
1.41
1.37
1.24
1.47
1.21
1.27
0.78
0.62
0.67
0.75
Total equity
62.2
340
297
-21.4
-82.6
-68.9
-119
-125
-157
-109
Total liabilities and equity
689
865
742
394
266
258
195
155
144
140
Shares outstanding
2.35
2.18
2.04
1.93
1.96
1.99
2.02
3.32
3.4
11
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
31.4
312
-2.7
-306
-66.3
12.1
-52.8
-56.1
-35.4
1.93
Depreciation and amortization
36.8
36.4
30.8
18.5
14.9
4.59
3.44
2.39
1
0.52
Stock-based compensation
6.19
4.26
10.2
11.9
7.8
2.83
5.05
5.07
4.74
4.35
Deferred income tax
-2.6
-297
-5.79
307
5.03
-0.71
1.1
0.05
-0.68
-1.19
Change in receivables
16
30
14.6
-12.2
15
2.96
4.13
0.45
-4.21
-3.16
Change in payables
-9.11
2.58
1.65
-16.3
-10.3
-8.44
-13
-3.42
3.7
6.08
Cash from operations
127
66.1
68.4
46.7
-22.4
-60.4
-44.9
-21.8
-5.03
-5.07
Capital expenditures
-23.3
-10.5
-3.92
-2.16
-2.71
-1.38
-0.86
0
-0
-0.07
Acquisitions
-9.41
0
0
Cash from investing
-80.9
-10.3
11.1
44.9
47.2
103
-0.77
0
2.25
-0.32
Debt issued
0
0
408
0
0
Debt repaid
-50.7
-59.8
-487
-45
-46.6
0
-30
0
-0.93
Stock issued
9.56
2.37
3.64
0.4
0
0
20.5
0
Share buybacks
-37.7
-39
-40.4
-20
0
Cash from financing
-76.6
-100
-124
-69
-49.3
-2.3
-2.22
2.98
0.06
3.18
Net change in cash
-30
-44.3
-44.8
22.5
-24.5
40.1
-47.9
-18.9
-2.72
-2.21
Free cash flow
104
55.6
64.5
44.5
-25.1
-61.8
-45.8
-21.8
-5.03
-5.13
Interest paid
22.7
21.2
24.1
20.9
15.7
12.5
15
22.9
23.8
14.6
Income taxes paid
18.3
18.3
7.14
2.69
2.06
2.46
3.3
-3.78
2.05
-0.01
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.49 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
26.6%
Gross profit / revenue.
Operating margin
-1.8%
Operating income / revenue.
EBITDA margin
-1.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-5.2%
Pre-tax income / revenue.
Net margin
-5.9%
Net income / revenue.
FCF margin
-1.3%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-1.1%
Cash from operations / revenue.
Return on assets (ROA)
-7.9%
Net income / average total assets.
Return on invested capital (ROIC)
-4.8%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
24.2%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
2.7%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.2%
Capital expenditures / revenue.
D&A / revenue
0.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
6.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
3.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-14.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-1.2%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
30.9%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-4.1%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y
-87.1%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-77.9%
EBITDA vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-2.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-10.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-12.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
210.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
76.6%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
41.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.17x
Current assets / current liabilities.
Quick ratio
1.03x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.48x
(Cash + short-term investments) / current liabilities.
Debt / assets
136.4%
Total debt / total assets.
Liabilities / assets
180.1%
Total liabilities / total assets.
Net debt
$163.0M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$16.09
Revenue / diluted weighted shares.
FCF per share
-$0.21
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.17
Cash from operations / diluted weighted shares.
Book value per share
-$9.64
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.34x
Market cap / revenue.
EV/Sales
1.24x
Enterprise value / revenue.
FCF yield
-3.8%
Free cash flow / market cap.
Earnings yield
-17.3%
Net income / market cap (the inverse of P/E).
What was ALTISOURCE PORTFOLIO SOLUTIONS S.A.'s revenue in fiscal 2025?
ALTISOURCE PORTFOLIO SOLUTIONS S.A. reported revenue of $171.0M for fiscal 2025, 6.8% higher than the year before.
Was ALTISOURCE PORTFOLIO SOLUTIONS S.A. profitable in fiscal 2025?
Yes. Net income was $1.6M, a net margin of 0.9%.
How much free cash flow did ALTISOURCE PORTFOLIO SOLUTIONS S.A. generate in fiscal 2025?
Cash from operations of $5.1M minus capital expenditures of $69.0K left free cash flow of -$5.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.